ahlam1399
09-07-2015, 01:48 PM
India rejects patent on Pfizer?s arthritis drug
MUMBAI, Sept 7 (Reuters) - India has again denied Pfizer Inc a patent on its rheumatoid arthritis drug tofacitinib, the latest setback for a multinational drugmaker seeking to enforce its intellectual property rights in the country.
http://rc.feedsportal.com/r/238385383915/u/49/f/654213/c/35217/s/49a1b197/sc/19/rc/1/rc.img (http://rc.feedsportal.com/r/238385383915/u/49/f/654213/c/35217/s/49a1b197/sc/19/rc/1/rc.htm)
http://rc.feedsportal.com/r/238385383915/u/49/f/654213/c/35217/s/49a1b197/sc/19/rc/2/rc.img (http://rc.feedsportal.com/r/238385383915/u/49/f/654213/c/35217/s/49a1b197/sc/19/rc/2/rc.htm)
http://rc.feedsportal.com/r/238385383915/u/49/f/654213/c/35217/s/49a1b197/sc/19/rc/3/rc.img (http://rc.feedsportal.com/r/238385383915/u/49/f/654213/c/35217/s/49a1b197/sc/19/rc/3/rc.htm)
http://da.feedsportal.com/r/238385383915/u/49/f/654213/c/35217/s/49a1b197/sc/19/a2.img (http://da.feedsportal.com/r/238385383915/u/49/f/654213/c/35217/s/49a1b197/sc/19/a2.htm)
http://adchoice.feedsportal.com/r/238385383915/u/49/f/654213/c/35217/s/49a1b197/sc/19/ach.img (http://adchoice.feedsportal.com/r/238385383915/u/49/f/654213/c/35217/s/49a1b197/sc/19/ach.htm)http://pi.feedsportal.com/r/238385383915/u/49/f/654213/c/35217/s/49a1b197/sc/19/a2t.imghttp://pi2.feedsportal.com/r/238385383915/u/49/f/654213/c/35217/s/49a1b197/sc/19/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/49a1b197/sc/19/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=R2FbnScYIlE:-at0_EGCGvM:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=R2FbnScYIlE:-at0_EGCGvM:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=R2FbnScYIlE:-at0_EGCGvM:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=R2FbnScYIlE:-at0_EGCGvM:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=R2FbnScYIlE:-at0_EGCGvM:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/R2FbnScYIlE
MUMBAI, Sept 7 (Reuters) - India has again denied Pfizer Inc a patent on its rheumatoid arthritis drug tofacitinib, the latest setback for a multinational drugmaker seeking to enforce its intellectual property rights in the country.
http://rc.feedsportal.com/r/238385383915/u/49/f/654213/c/35217/s/49a1b197/sc/19/rc/1/rc.img (http://rc.feedsportal.com/r/238385383915/u/49/f/654213/c/35217/s/49a1b197/sc/19/rc/1/rc.htm)
http://rc.feedsportal.com/r/238385383915/u/49/f/654213/c/35217/s/49a1b197/sc/19/rc/2/rc.img (http://rc.feedsportal.com/r/238385383915/u/49/f/654213/c/35217/s/49a1b197/sc/19/rc/2/rc.htm)
http://rc.feedsportal.com/r/238385383915/u/49/f/654213/c/35217/s/49a1b197/sc/19/rc/3/rc.img (http://rc.feedsportal.com/r/238385383915/u/49/f/654213/c/35217/s/49a1b197/sc/19/rc/3/rc.htm)
http://da.feedsportal.com/r/238385383915/u/49/f/654213/c/35217/s/49a1b197/sc/19/a2.img (http://da.feedsportal.com/r/238385383915/u/49/f/654213/c/35217/s/49a1b197/sc/19/a2.htm)
http://adchoice.feedsportal.com/r/238385383915/u/49/f/654213/c/35217/s/49a1b197/sc/19/ach.img (http://adchoice.feedsportal.com/r/238385383915/u/49/f/654213/c/35217/s/49a1b197/sc/19/ach.htm)http://pi.feedsportal.com/r/238385383915/u/49/f/654213/c/35217/s/49a1b197/sc/19/a2t.imghttp://pi2.feedsportal.com/r/238385383915/u/49/f/654213/c/35217/s/49a1b197/sc/19/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/49a1b197/sc/19/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=R2FbnScYIlE:-at0_EGCGvM:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=R2FbnScYIlE:-at0_EGCGvM:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=R2FbnScYIlE:-at0_EGCGvM:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=R2FbnScYIlE:-at0_EGCGvM:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=R2FbnScYIlE:-at0_EGCGvM:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/R2FbnScYIlE